/
ORMP
$4.38+$0.11 (+2.58%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$177.6M
42M shares
52-week range
$1.98 – $5.19
75% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-10.83
Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
www.oramed.com- Employees
- 13
- IPO / List date
- Apr 19, 2004
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds ORMP.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 147,700 | $502.2K |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 5.71% ($0.25/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-01-16 | $0.2500 | 2026-01-26 |
Stock splits
| Execution date | Ratio |
|---|---|
| 2013-01-23 | 1-for-12reverse |
Recent trades on TradeandTell
No one on the platform has traded ORMP yet.
